Table 1.
Basic information on COVID-19 vaccination in Korea, Japan and Singapore
| Korea | Japan | Singapore | |
|---|---|---|---|
| Population (millions) | 51.27 | 12.65 | 5.85 |
| Density of population(P/km2) | 359 | 390 | 8554 |
| GDP per capita ($ million) | 3.22 | 4.13 | 8.27 |
| Percentage of population over 65 years old(%) | 13.91 | 27.05 | 12.92 |
| Expected life expectancy (years) | 83.03 | 84.63 | 83.62 |
| Cumulative number of confirmed cases (/ million) | 603,348.77 | 272,420.29 | 424,296.73 |
| Cumulative number of deaths (/ million) | 666.05 | 601.96 | 305.48 |
| Start date of vaccination | February 26, 2021 | February 17, 2021 | December 30, 2020 |
| Cumulative vaccinations (millions) | 129.65 | 385.75 | 14.72 |
| COVID-19 vaccination rate(%) | 86.43 | 84.47 | 91.55 |
| Share of people with fully vaccinated(%) | 85.64 | 83.40 | 90.85 |
| Share of people only partly vaccinated(%) | 0.79 | 1.07 | 0.70 |
| Share of people with booster vaccinated(%) | 79.76 | 141.71 | 78.77 |
| Vaccines Appointment | Vaccine appointments are made online or by phone | Vaccine appointments are made online or by phone | Vaccine appointments are made online or by phone |
| Free vaccination or not | Free vaccination for the entire population | Free vaccination for the entire population | Free vaccination for the entire population |
| Vaccines administered | Pfizer/BioNTech, Moderna, AstraZeneca, Novavax, Johnson&Johnson |
Pfizer/BioNTech, Moderna, AstraZeneca |
Pfizer-BioNTech/Comirnaty Moderna/Spikevax Novavax/Nuvaxovid Sinovac-CoronaVac |
The start date of vaccination is the local time of each country